MSA
CELG

Marino Stram & Associates’s Celgene Corp CELG Stock Holding History

Marino Stram & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-924
Closed -$87K – 654
2019
Q1 		$87K Buy
924
+16
+2% +$1.4K 0.06% 129
2018
Q4 		$58K Sell
908
-2,019
-69% -$149K 0.05% 144
2018
Q3 		$251K Sell
2,927
-518
-15% -$45.8K 0.2% 70
2018
Q2 		$274K Sell
3,445
-250
-7% -$20.8K 0.24% 65
2018
Q1 		$330K Buy
3,695
+150
+4% +$14.4K 0.31% 59
2017
Q4 		$370K Buy
+3,545
New +$400K 0.34% 51

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Marino Stram & Associates's CELG Position: Q2 2019 in Review

Marino Stram & Associates sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 924 shares — an estimated $87K sold.

Marino Stram & Associates first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $370K in Q4 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Marino Stram & Associates reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 924 Celgene Corp shares in Q2 2019, an estimated $87K.
  • Marino Stram & Associates first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Celgene Corp position peaked at $370K in Q4 2017.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.